Driving
Asia-focused
therapeutic innovation
in oncology

AUM is committed to addressing the unmet medical needs by developing innovative and affordable oncology therapeutics for Asia

WHO ARE WE

AUM Biosciences is an oncology-focused biotechnology company.
Harnessing the power of digital and precision medicine to disrupt the drug development process, AUM aims to accelerate development timelines, manage trial costs and improve outcomes for patients in Asia and around the world.
boudewijn-huysmans-557864-unsplash

AREA OF FOCUS

AUM is committed to developing new treatments to address
the rapidly growing burden of cancer in Asia.
We will focus on the early-stage development of innovative medicines for the treatment of Asia-prevalent cancers, seeking global partners for late-stage clinical development and commercialization.
Small Molecules

SMALL MOLECULES IN ONCOLOGY

Application of Precision Medicine

APPLICATION OF PRECISION MEDICINE

Trial Digitalisation

TRIAL DIGITALISATION

OUR TEAM

       Led by a highly-experienced management team that applies over 50 years of global drug development and commercialisation expertise to promote innovation in medical science in Asia for global impact.
The team is supported by a world-renowned oncology experts on the Board and as scientific advisors.
More

WHO WE WORK WITH

AUM is partnering and collaborating with leading international research institutes, clinicians and pharmaceutical companies.
molecule-2082634

    60% of cancers worldwide  are diagnosed in Asia

  10.6 million new cases in Asia by 2030

8 million of new cases will come from less developed regions

CAREERS

AUM is building its team and is interested to hear from candidates. To view our current job openings, please visit our LinkedIn page or email us.

CONTACT US

  • Level 40
    Ocean Financial Centre
    10 Collyer Quay
    Singapore
    049315
    Tel: +65 6808 6034
    Fax: +65 6808 6699